Hubbard-Hall acquired the assets of BioConversion Technology (BCT), a supplier of biologics and related chemistries for wastewater treatment.
Formerly headquartered in Georgia, Bioconversion was founded in 2000 by Kathleen Renzi.
“It has been a rewarding 30-plus years, and as I retire, l am both happy and proud that Hubbard-Hall will carry BioConversion forward,” Renzi says.
BCT products are custom blends of specially selected bacterial strains for the metal finishing, food, pulp paper, and petrochemical markets. The bacteria work under aerobic and anaerobic conditions with no caustics or acids so as to not cause harm to pipes or wastewater equipment.
Jeremy Morgan, previously a vice president of technology at BCT, has joined Hubbard-Hall as the Product Manager for Biologics within the company’s AquaPure product line of wastewater specialties.
Morgan is a graduate of the Georgia Institute of Technology with a degree in chemical engineering and is a frequent speaker at water technology conferences. He will report to Robin Deal, AquaPure Product Manager.
“The BCT line of products - combined with Jeremy’s expertise in biologics – round out our offerings to our industrial customer base,” said Molly Kellogg, CEO of Hubbard-Hall. “Bioaugmentation in metal finishing wastewater treatment is becoming more common as limits continue to tighten around Phosphorus, FOG, and BOD.”
“We now have a broader line to help our customers and, as always, the best technical team in the business.”
Founded in 1849, Hubbard-Hall is the oldest independent chemical distributor in the United States. Hubbard-Hall helps manufacturers reduce cost, complexity, and chemical consumption through process efficiencies and product innovations.
Visit www.hubbardhall.com
